DRAIC and neoplasm: This study identifies STAT3 and miR-21 as important players in the regulation of PCAT29. Furthermore, it provides a clinically relevant drug, resveratrol, which could abrogate IL-6 signaling to boost the expression of PCAT29 and facilitate its anti-tumor action.